Global Famciclovir Market Growth 2025-2031
The global Famciclovir market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Famciclovir is an antiviral drug. It slows the growth and spread of the herpes virus so that the body can fight off the infection. Famciclovir will not cure herpes, but it can lessen the symptoms of the infections.
United States market for Famciclovir is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Famciclovir is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Famciclovir is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Famciclovir players cover Novartis, Mylan, Teva, Cipla, Hikma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the ?Famciclovir Industry Forecast? looks at past sales and reviews total world Famciclovir sales in 2024, providing a comprehensive analysis by region and market sector of projected Famciclovir sales for 2025 through 2031. With Famciclovir sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Famciclovir industry.
This Insight Report provides a comprehensive analysis of the global Famciclovir landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Famciclovir portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Famciclovir market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Famciclovir and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Famciclovir.
This report presents a comprehensive overview, market shares, and growth opportunities of Famciclovir market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Famciclovir market?
What factors are driving Famciclovir market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Famciclovir market opportunities vary by end market size?
How does Famciclovir break out by Type, by Application?
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Famciclovir is an antiviral drug. It slows the growth and spread of the herpes virus so that the body can fight off the infection. Famciclovir will not cure herpes, but it can lessen the symptoms of the infections.
United States market for Famciclovir is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Famciclovir is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Famciclovir is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Famciclovir players cover Novartis, Mylan, Teva, Cipla, Hikma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the ?Famciclovir Industry Forecast? looks at past sales and reviews total world Famciclovir sales in 2024, providing a comprehensive analysis by region and market sector of projected Famciclovir sales for 2025 through 2031. With Famciclovir sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Famciclovir industry.
This Insight Report provides a comprehensive analysis of the global Famciclovir landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Famciclovir portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Famciclovir market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Famciclovir and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Famciclovir.
This report presents a comprehensive overview, market shares, and growth opportunities of Famciclovir market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- 125 mg Tablets
- 250 mg Tablets
- 500 mg Tablets
- Cold Sores
- Genital Herpes
- Shingles
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Novartis
- Mylan
- Teva
- Cipla
- Hikma
- Apotex
- Aurobindo Pharma
- Macleods Pharmaceuticals
- Beijing Jialin Pharmaceutical
- HETERO
- Hainan choitec Pharmaceuticals
- Shandong Luoxin Pharmaceutical Group
- Chengdu Diao Pharmaceutical Group
- HISUN
What is the 10-year outlook for the global Famciclovir market?
What factors are driving Famciclovir market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Famciclovir market opportunities vary by end market size?
How does Famciclovir break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Famciclovir Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Famciclovir by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Famciclovir by Country/Region, 2020, 2024 & 2031
2.2 Famciclovir Segment by Type
2.2.1 125 mg Tablets
2.2.2 250 mg Tablets
2.2.3 500 mg Tablets
2.3 Famciclovir Sales by Type
2.3.1 Global Famciclovir Sales Market Share by Type (2020-2025)
2.3.2 Global Famciclovir Revenue and Market Share by Type (2020-2025)
2.3.3 Global Famciclovir Sale Price by Type (2020-2025)
2.4 Famciclovir Segment by Application
2.4.1 Cold Sores
2.4.2 Genital Herpes
2.4.3 Shingles
2.5 Famciclovir Sales by Application
2.5.1 Global Famciclovir Sale Market Share by Application (2020-2025)
2.5.2 Global Famciclovir Revenue and Market Share by Application (2020-2025)
2.5.3 Global Famciclovir Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Famciclovir Breakdown Data by Company
3.1.1 Global Famciclovir Annual Sales by Company (2020-2025)
3.1.2 Global Famciclovir Sales Market Share by Company (2020-2025)
3.2 Global Famciclovir Annual Revenue by Company (2020-2025)
3.2.1 Global Famciclovir Revenue by Company (2020-2025)
3.2.2 Global Famciclovir Revenue Market Share by Company (2020-2025)
3.3 Global Famciclovir Sale Price by Company
3.4 Key Manufacturers Famciclovir Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Famciclovir Product Location Distribution
3.4.2 Players Famciclovir Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR FAMCICLOVIR BY GEOGRAPHIC REGION
4.1 World Historic Famciclovir Market Size by Geographic Region (2020-2025)
4.1.1 Global Famciclovir Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Famciclovir Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Famciclovir Market Size by Country/Region (2020-2025)
4.2.1 Global Famciclovir Annual Sales by Country/Region (2020-2025)
4.2.2 Global Famciclovir Annual Revenue by Country/Region (2020-2025)
4.3 Americas Famciclovir Sales Growth
4.4 APAC Famciclovir Sales Growth
4.5 Europe Famciclovir Sales Growth
4.6 Middle East & Africa Famciclovir Sales Growth
5 AMERICAS
5.1 Americas Famciclovir Sales by Country
5.1.1 Americas Famciclovir Sales by Country (2020-2025)
5.1.2 Americas Famciclovir Revenue by Country (2020-2025)
5.2 Americas Famciclovir Sales by Type (2020-2025)
5.3 Americas Famciclovir Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Famciclovir Sales by Region
6.1.1 APAC Famciclovir Sales by Region (2020-2025)
6.1.2 APAC Famciclovir Revenue by Region (2020-2025)
6.2 APAC Famciclovir Sales by Type (2020-2025)
6.3 APAC Famciclovir Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Famciclovir by Country
7.1.1 Europe Famciclovir Sales by Country (2020-2025)
7.1.2 Europe Famciclovir Revenue by Country (2020-2025)
7.2 Europe Famciclovir Sales by Type (2020-2025)
7.3 Europe Famciclovir Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Famciclovir by Country
8.1.1 Middle East & Africa Famciclovir Sales by Country (2020-2025)
8.1.2 Middle East & Africa Famciclovir Revenue by Country (2020-2025)
8.2 Middle East & Africa Famciclovir Sales by Type (2020-2025)
8.3 Middle East & Africa Famciclovir Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Famciclovir
10.3 Manufacturing Process Analysis of Famciclovir
10.4 Industry Chain Structure of Famciclovir
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Famciclovir Distributors
11.3 Famciclovir Customer
12 WORLD FORECAST REVIEW FOR FAMCICLOVIR BY GEOGRAPHIC REGION
12.1 Global Famciclovir Market Size Forecast by Region
12.1.1 Global Famciclovir Forecast by Region (2026-2031)
12.1.2 Global Famciclovir Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Famciclovir Forecast by Type (2026-2031)
12.7 Global Famciclovir Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Novartis
13.1.1 Novartis Company Information
13.1.2 Novartis Famciclovir Product Portfolios and Specifications
13.1.3 Novartis Famciclovir Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Novartis Main Business Overview
13.1.5 Novartis Latest Developments
13.2 Mylan
13.2.1 Mylan Company Information
13.2.2 Mylan Famciclovir Product Portfolios and Specifications
13.2.3 Mylan Famciclovir Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Mylan Main Business Overview
13.2.5 Mylan Latest Developments
13.3 Teva
13.3.1 Teva Company Information
13.3.2 Teva Famciclovir Product Portfolios and Specifications
13.3.3 Teva Famciclovir Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Teva Main Business Overview
13.3.5 Teva Latest Developments
13.4 Cipla
13.4.1 Cipla Company Information
13.4.2 Cipla Famciclovir Product Portfolios and Specifications
13.4.3 Cipla Famciclovir Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Cipla Main Business Overview
13.4.5 Cipla Latest Developments
13.5 Hikma
13.5.1 Hikma Company Information
13.5.2 Hikma Famciclovir Product Portfolios and Specifications
13.5.3 Hikma Famciclovir Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Hikma Main Business Overview
13.5.5 Hikma Latest Developments
13.6 Apotex
13.6.1 Apotex Company Information
13.6.2 Apotex Famciclovir Product Portfolios and Specifications
13.6.3 Apotex Famciclovir Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Apotex Main Business Overview
13.6.5 Apotex Latest Developments
13.7 Aurobindo Pharma
13.7.1 Aurobindo Pharma Company Information
13.7.2 Aurobindo Pharma Famciclovir Product Portfolios and Specifications
13.7.3 Aurobindo Pharma Famciclovir Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Aurobindo Pharma Main Business Overview
13.7.5 Aurobindo Pharma Latest Developments
13.8 Macleods Pharmaceuticals
13.8.1 Macleods Pharmaceuticals Company Information
13.8.2 Macleods Pharmaceuticals Famciclovir Product Portfolios and Specifications
13.8.3 Macleods Pharmaceuticals Famciclovir Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Macleods Pharmaceuticals Main Business Overview
13.8.5 Macleods Pharmaceuticals Latest Developments
13.9 Beijing Jialin Pharmaceutical
13.9.1 Beijing Jialin Pharmaceutical Company Information
13.9.2 Beijing Jialin Pharmaceutical Famciclovir Product Portfolios and Specifications
13.9.3 Beijing Jialin Pharmaceutical Famciclovir Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Beijing Jialin Pharmaceutical Main Business Overview
13.9.5 Beijing Jialin Pharmaceutical Latest Developments
13.10 HETERO
13.10.1 HETERO Company Information
13.10.2 HETERO Famciclovir Product Portfolios and Specifications
13.10.3 HETERO Famciclovir Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 HETERO Main Business Overview
13.10.5 HETERO Latest Developments
13.11 Hainan choitec Pharmaceuticals
13.11.1 Hainan choitec Pharmaceuticals Company Information
13.11.2 Hainan choitec Pharmaceuticals Famciclovir Product Portfolios and Specifications
13.11.3 Hainan choitec Pharmaceuticals Famciclovir Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Hainan choitec Pharmaceuticals Main Business Overview
13.11.5 Hainan choitec Pharmaceuticals Latest Developments
13.12 Shandong Luoxin Pharmaceutical Group
13.12.1 Shandong Luoxin Pharmaceutical Group Company Information
13.12.2 Shandong Luoxin Pharmaceutical Group Famciclovir Product Portfolios and Specifications
13.12.3 Shandong Luoxin Pharmaceutical Group Famciclovir Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Shandong Luoxin Pharmaceutical Group Main Business Overview
13.12.5 Shandong Luoxin Pharmaceutical Group Latest Developments
13.13 Chengdu Diao Pharmaceutical Group
13.13.1 Chengdu Diao Pharmaceutical Group Company Information
13.13.2 Chengdu Diao Pharmaceutical Group Famciclovir Product Portfolios and Specifications
13.13.3 Chengdu Diao Pharmaceutical Group Famciclovir Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Chengdu Diao Pharmaceutical Group Main Business Overview
13.13.5 Chengdu Diao Pharmaceutical Group Latest Developments
13.14 HISUN
13.14.1 HISUN Company Information
13.14.2 HISUN Famciclovir Product Portfolios and Specifications
13.14.3 HISUN Famciclovir Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 HISUN Main Business Overview
13.14.5 HISUN Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Famciclovir Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Famciclovir by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Famciclovir by Country/Region, 2020, 2024 & 2031
2.2 Famciclovir Segment by Type
2.2.1 125 mg Tablets
2.2.2 250 mg Tablets
2.2.3 500 mg Tablets
2.3 Famciclovir Sales by Type
2.3.1 Global Famciclovir Sales Market Share by Type (2020-2025)
2.3.2 Global Famciclovir Revenue and Market Share by Type (2020-2025)
2.3.3 Global Famciclovir Sale Price by Type (2020-2025)
2.4 Famciclovir Segment by Application
2.4.1 Cold Sores
2.4.2 Genital Herpes
2.4.3 Shingles
2.5 Famciclovir Sales by Application
2.5.1 Global Famciclovir Sale Market Share by Application (2020-2025)
2.5.2 Global Famciclovir Revenue and Market Share by Application (2020-2025)
2.5.3 Global Famciclovir Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Famciclovir Breakdown Data by Company
3.1.1 Global Famciclovir Annual Sales by Company (2020-2025)
3.1.2 Global Famciclovir Sales Market Share by Company (2020-2025)
3.2 Global Famciclovir Annual Revenue by Company (2020-2025)
3.2.1 Global Famciclovir Revenue by Company (2020-2025)
3.2.2 Global Famciclovir Revenue Market Share by Company (2020-2025)
3.3 Global Famciclovir Sale Price by Company
3.4 Key Manufacturers Famciclovir Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Famciclovir Product Location Distribution
3.4.2 Players Famciclovir Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR FAMCICLOVIR BY GEOGRAPHIC REGION
4.1 World Historic Famciclovir Market Size by Geographic Region (2020-2025)
4.1.1 Global Famciclovir Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Famciclovir Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Famciclovir Market Size by Country/Region (2020-2025)
4.2.1 Global Famciclovir Annual Sales by Country/Region (2020-2025)
4.2.2 Global Famciclovir Annual Revenue by Country/Region (2020-2025)
4.3 Americas Famciclovir Sales Growth
4.4 APAC Famciclovir Sales Growth
4.5 Europe Famciclovir Sales Growth
4.6 Middle East & Africa Famciclovir Sales Growth
5 AMERICAS
5.1 Americas Famciclovir Sales by Country
5.1.1 Americas Famciclovir Sales by Country (2020-2025)
5.1.2 Americas Famciclovir Revenue by Country (2020-2025)
5.2 Americas Famciclovir Sales by Type (2020-2025)
5.3 Americas Famciclovir Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Famciclovir Sales by Region
6.1.1 APAC Famciclovir Sales by Region (2020-2025)
6.1.2 APAC Famciclovir Revenue by Region (2020-2025)
6.2 APAC Famciclovir Sales by Type (2020-2025)
6.3 APAC Famciclovir Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Famciclovir by Country
7.1.1 Europe Famciclovir Sales by Country (2020-2025)
7.1.2 Europe Famciclovir Revenue by Country (2020-2025)
7.2 Europe Famciclovir Sales by Type (2020-2025)
7.3 Europe Famciclovir Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Famciclovir by Country
8.1.1 Middle East & Africa Famciclovir Sales by Country (2020-2025)
8.1.2 Middle East & Africa Famciclovir Revenue by Country (2020-2025)
8.2 Middle East & Africa Famciclovir Sales by Type (2020-2025)
8.3 Middle East & Africa Famciclovir Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Famciclovir
10.3 Manufacturing Process Analysis of Famciclovir
10.4 Industry Chain Structure of Famciclovir
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Famciclovir Distributors
11.3 Famciclovir Customer
12 WORLD FORECAST REVIEW FOR FAMCICLOVIR BY GEOGRAPHIC REGION
12.1 Global Famciclovir Market Size Forecast by Region
12.1.1 Global Famciclovir Forecast by Region (2026-2031)
12.1.2 Global Famciclovir Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Famciclovir Forecast by Type (2026-2031)
12.7 Global Famciclovir Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Novartis
13.1.1 Novartis Company Information
13.1.2 Novartis Famciclovir Product Portfolios and Specifications
13.1.3 Novartis Famciclovir Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Novartis Main Business Overview
13.1.5 Novartis Latest Developments
13.2 Mylan
13.2.1 Mylan Company Information
13.2.2 Mylan Famciclovir Product Portfolios and Specifications
13.2.3 Mylan Famciclovir Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Mylan Main Business Overview
13.2.5 Mylan Latest Developments
13.3 Teva
13.3.1 Teva Company Information
13.3.2 Teva Famciclovir Product Portfolios and Specifications
13.3.3 Teva Famciclovir Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Teva Main Business Overview
13.3.5 Teva Latest Developments
13.4 Cipla
13.4.1 Cipla Company Information
13.4.2 Cipla Famciclovir Product Portfolios and Specifications
13.4.3 Cipla Famciclovir Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Cipla Main Business Overview
13.4.5 Cipla Latest Developments
13.5 Hikma
13.5.1 Hikma Company Information
13.5.2 Hikma Famciclovir Product Portfolios and Specifications
13.5.3 Hikma Famciclovir Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Hikma Main Business Overview
13.5.5 Hikma Latest Developments
13.6 Apotex
13.6.1 Apotex Company Information
13.6.2 Apotex Famciclovir Product Portfolios and Specifications
13.6.3 Apotex Famciclovir Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Apotex Main Business Overview
13.6.5 Apotex Latest Developments
13.7 Aurobindo Pharma
13.7.1 Aurobindo Pharma Company Information
13.7.2 Aurobindo Pharma Famciclovir Product Portfolios and Specifications
13.7.3 Aurobindo Pharma Famciclovir Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Aurobindo Pharma Main Business Overview
13.7.5 Aurobindo Pharma Latest Developments
13.8 Macleods Pharmaceuticals
13.8.1 Macleods Pharmaceuticals Company Information
13.8.2 Macleods Pharmaceuticals Famciclovir Product Portfolios and Specifications
13.8.3 Macleods Pharmaceuticals Famciclovir Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Macleods Pharmaceuticals Main Business Overview
13.8.5 Macleods Pharmaceuticals Latest Developments
13.9 Beijing Jialin Pharmaceutical
13.9.1 Beijing Jialin Pharmaceutical Company Information
13.9.2 Beijing Jialin Pharmaceutical Famciclovir Product Portfolios and Specifications
13.9.3 Beijing Jialin Pharmaceutical Famciclovir Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Beijing Jialin Pharmaceutical Main Business Overview
13.9.5 Beijing Jialin Pharmaceutical Latest Developments
13.10 HETERO
13.10.1 HETERO Company Information
13.10.2 HETERO Famciclovir Product Portfolios and Specifications
13.10.3 HETERO Famciclovir Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 HETERO Main Business Overview
13.10.5 HETERO Latest Developments
13.11 Hainan choitec Pharmaceuticals
13.11.1 Hainan choitec Pharmaceuticals Company Information
13.11.2 Hainan choitec Pharmaceuticals Famciclovir Product Portfolios and Specifications
13.11.3 Hainan choitec Pharmaceuticals Famciclovir Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Hainan choitec Pharmaceuticals Main Business Overview
13.11.5 Hainan choitec Pharmaceuticals Latest Developments
13.12 Shandong Luoxin Pharmaceutical Group
13.12.1 Shandong Luoxin Pharmaceutical Group Company Information
13.12.2 Shandong Luoxin Pharmaceutical Group Famciclovir Product Portfolios and Specifications
13.12.3 Shandong Luoxin Pharmaceutical Group Famciclovir Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Shandong Luoxin Pharmaceutical Group Main Business Overview
13.12.5 Shandong Luoxin Pharmaceutical Group Latest Developments
13.13 Chengdu Diao Pharmaceutical Group
13.13.1 Chengdu Diao Pharmaceutical Group Company Information
13.13.2 Chengdu Diao Pharmaceutical Group Famciclovir Product Portfolios and Specifications
13.13.3 Chengdu Diao Pharmaceutical Group Famciclovir Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Chengdu Diao Pharmaceutical Group Main Business Overview
13.13.5 Chengdu Diao Pharmaceutical Group Latest Developments
13.14 HISUN
13.14.1 HISUN Company Information
13.14.2 HISUN Famciclovir Product Portfolios and Specifications
13.14.3 HISUN Famciclovir Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 HISUN Main Business Overview
13.14.5 HISUN Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Famciclovir Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Famciclovir Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of 125 mgTablets
Table 4. Major Players of 250 mgTablets
Table 5. Major Players of 500 mgTablets
Table 6. Global Famciclovir Sales by Type (2020-2025) & (K Units)
Table 7. Global Famciclovir Sales Market Share by Type (2020-2025)
Table 8. Global Famciclovir Revenue by Type (2020-2025) & ($ million)
Table 9. Global Famciclovir Revenue Market Share by Type (2020-2025)
Table 10. Global Famciclovir Sale Price by Type (2020-2025) & (USD/Unit)
Table 11. Global Famciclovir Sale by Application (2020-2025) & (K Units)
Table 12. Global Famciclovir Sale Market Share by Application (2020-2025)
Table 13. Global Famciclovir Revenue by Application (2020-2025) & ($ million)
Table 14. Global Famciclovir Revenue Market Share by Application (2020-2025)
Table 15. Global Famciclovir Sale Price by Application (2020-2025) & (USD/Unit)
Table 16. Global Famciclovir Sales by Company (2020-2025) & (K Units)
Table 17. Global Famciclovir Sales Market Share by Company (2020-2025)
Table 18. Global Famciclovir Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Famciclovir Revenue Market Share by Company (2020-2025)
Table 20. Global Famciclovir Sale Price by Company (2020-2025) & (USD/Unit)
Table 21. Key Manufacturers Famciclovir Producing Area Distribution and Sales Area
Table 22. Players Famciclovir Products Offered
Table 23. Famciclovir Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Famciclovir Sales by Geographic Region (2020-2025) & (K Units)
Table 27. Global Famciclovir Sales Market Share Geographic Region (2020-2025)
Table 28. Global Famciclovir Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Famciclovir Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Famciclovir Sales by Country/Region (2020-2025) & (K Units)
Table 31. Global Famciclovir Sales Market Share by Country/Region (2020-2025)
Table 32. Global Famciclovir Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Famciclovir Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Famciclovir Sales by Country (2020-2025) & (K Units)
Table 35. Americas Famciclovir Sales Market Share by Country (2020-2025)
Table 36. Americas Famciclovir Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Famciclovir Sales by Type (2020-2025) & (K Units)
Table 38. Americas Famciclovir Sales by Application (2020-2025) & (K Units)
Table 39. APAC Famciclovir Sales by Region (2020-2025) & (K Units)
Table 40. APAC Famciclovir Sales Market Share by Region (2020-2025)
Table 41. APAC Famciclovir Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Famciclovir Sales by Type (2020-2025) & (K Units)
Table 43. APAC Famciclovir Sales by Application (2020-2025) & (K Units)
Table 44. Europe Famciclovir Sales by Country (2020-2025) & (K Units)
Table 45. Europe Famciclovir Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Famciclovir Sales by Type (2020-2025) & (K Units)
Table 47. Europe Famciclovir Sales by Application (2020-2025) & (K Units)
Table 48. Middle East & Africa Famciclovir Sales by Country (2020-2025) & (K Units)
Table 49. Middle East & Africa Famciclovir Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Famciclovir Sales by Type (2020-2025) & (K Units)
Table 51. Middle East & Africa Famciclovir Sales by Application (2020-2025) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Famciclovir
Table 53. Key Market Challenges & Risks of Famciclovir
Table 54. Key Industry Trends of Famciclovir
Table 55. Famciclovir Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Famciclovir Distributors List
Table 58. Famciclovir Customer List
Table 59. Global Famciclovir Sales Forecast by Region (2026-2031) & (K Units)
Table 60. Global Famciclovir Revenue Forecast by Region (2026-2031) & ($ millions)
Table 61. Americas Famciclovir Sales Forecast by Country (2026-2031) & (K Units)
Table 62. Americas Famciclovir Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 63. APAC Famciclovir Sales Forecast by Region (2026-2031) & (K Units)
Table 64. APAC Famciclovir Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Europe Famciclovir Sales Forecast by Country (2026-2031) & (K Units)
Table 66. Europe Famciclovir Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Famciclovir Sales Forecast by Country (2026-2031) & (K Units)
Table 68. Middle East & Africa Famciclovir Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Global Famciclovir Sales Forecast by Type (2026-2031) & (K Units)
Table 70. Global Famciclovir Revenue Forecast by Type (2026-2031) & ($ millions)
Table 71. Global Famciclovir Sales Forecast by Application (2026-2031) & (K Units)
Table 72. Global Famciclovir Revenue Forecast by Application (2026-2031) & ($ millions)
Table 73. Novartis Basic Information, Famciclovir Manufacturing Base, Sales Area and Its Competitors
Table 74. Novartis Famciclovir Product Portfolios and Specifications
Table 75. Novartis Famciclovir Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Novartis Main Business
Table 77. Novartis Latest Developments
Table 78. Mylan Basic Information, Famciclovir Manufacturing Base, Sales Area and Its Competitors
Table 79. Mylan Famciclovir Product Portfolios and Specifications
Table 80. Mylan Famciclovir Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 81. Mylan Main Business
Table 82. Mylan Latest Developments
Table 83. Teva Basic Information, Famciclovir Manufacturing Base, Sales Area and Its Competitors
Table 84. Teva Famciclovir Product Portfolios and Specifications
Table 85. Teva Famciclovir Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. Teva Main Business
Table 87. Teva Latest Developments
Table 88. Cipla Basic Information, Famciclovir Manufacturing Base, Sales Area and Its Competitors
Table 89. Cipla Famciclovir Product Portfolios and Specifications
Table 90. Cipla Famciclovir Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 91. Cipla Main Business
Table 92. Cipla Latest Developments
Table 93. Hikma Basic Information, Famciclovir Manufacturing Base, Sales Area and Its Competitors
Table 94. Hikma Famciclovir Product Portfolios and Specifications
Table 95. Hikma Famciclovir Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 96. Hikma Main Business
Table 97. Hikma Latest Developments
Table 98. Apotex Basic Information, Famciclovir Manufacturing Base, Sales Area and Its Competitors
Table 99. Apotex Famciclovir Product Portfolios and Specifications
Table 100. Apotex Famciclovir Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 101. Apotex Main Business
Table 102. Apotex Latest Developments
Table 103. Aurobindo Pharma Basic Information, Famciclovir Manufacturing Base, Sales Area and Its Competitors
Table 104. Aurobindo Pharma Famciclovir Product Portfolios and Specifications
Table 105. Aurobindo Pharma Famciclovir Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 106. Aurobindo Pharma Main Business
Table 107. Aurobindo Pharma Latest Developments
Table 108. Macleods Pharmaceuticals Basic Information, Famciclovir Manufacturing Base, Sales Area and Its Competitors
Table 109. Macleods Pharmaceuticals Famciclovir Product Portfolios and Specifications
Table 110. Macleods Pharmaceuticals Famciclovir Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 111. Macleods Pharmaceuticals Main Business
Table 112. Macleods Pharmaceuticals Latest Developments
Table 113. Beijing Jialin Pharmaceutical Basic Information, Famciclovir Manufacturing Base, Sales Area and Its Competitors
Table 114. Beijing Jialin Pharmaceutical Famciclovir Product Portfolios and Specifications
Table 115. Beijing Jialin Pharmaceutical Famciclovir Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 116. Beijing Jialin Pharmaceutical Main Business
Table 117. Beijing Jialin Pharmaceutical Latest Developments
Table 118. HETERO Basic Information, Famciclovir Manufacturing Base, Sales Area and Its Competitors
Table 119. HETERO Famciclovir Product Portfolios and Specifications
Table 120. HETERO Famciclovir Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 121. HETERO Main Business
Table 122. HETERO Latest Developments
Table 123. Hainan choitec Pharmaceuticals Basic Information, Famciclovir Manufacturing Base, Sales Area and Its Competitors
Table 124. Hainan choitec Pharmaceuticals Famciclovir Product Portfolios and Specifications
Table 125. Hainan choitec Pharmaceuticals Famciclovir Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 126. Hainan choitec Pharmaceuticals Main Business
Table 127. Hainan choitec Pharmaceuticals Latest Developments
Table 128. Shandong Luoxin Pharmaceutical Group Basic Information, Famciclovir Manufacturing Base, Sales Area and Its Competitors
Table 129. Shandong Luoxin Pharmaceutical Group Famciclovir Product Portfolios and Specifications
Table 130. Shandong Luoxin Pharmaceutical Group Famciclovir Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 131. Shandong Luoxin Pharmaceutical Group Main Business
Table 132. Shandong Luoxin Pharmaceutical Group Latest Developments
Table 133. Chengdu Diao Pharmaceutical Group Basic Information, Famciclovir Manufacturing Base, Sales Area and Its Competitors
Table 134. Chengdu Diao Pharmaceutical Group Famciclovir Product Portfolios and Specifications
Table 135. Chengdu Diao Pharmaceutical Group Famciclovir Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 136. Chengdu Diao Pharmaceutical Group Main Business
Table 137. Chengdu Diao Pharmaceutical Group Latest Developments
Table 138. HISUN Basic Information, Famciclovir Manufacturing Base, Sales Area and Its Competitors
Table 139. HISUN Famciclovir Product Portfolios and Specifications
Table 140. HISUN Famciclovir Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 141. HISUN Main Business
Table 142. HISUN Latest Developments
Table 1. Famciclovir Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Famciclovir Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of 125 mgTablets
Table 4. Major Players of 250 mgTablets
Table 5. Major Players of 500 mgTablets
Table 6. Global Famciclovir Sales by Type (2020-2025) & (K Units)
Table 7. Global Famciclovir Sales Market Share by Type (2020-2025)
Table 8. Global Famciclovir Revenue by Type (2020-2025) & ($ million)
Table 9. Global Famciclovir Revenue Market Share by Type (2020-2025)
Table 10. Global Famciclovir Sale Price by Type (2020-2025) & (USD/Unit)
Table 11. Global Famciclovir Sale by Application (2020-2025) & (K Units)
Table 12. Global Famciclovir Sale Market Share by Application (2020-2025)
Table 13. Global Famciclovir Revenue by Application (2020-2025) & ($ million)
Table 14. Global Famciclovir Revenue Market Share by Application (2020-2025)
Table 15. Global Famciclovir Sale Price by Application (2020-2025) & (USD/Unit)
Table 16. Global Famciclovir Sales by Company (2020-2025) & (K Units)
Table 17. Global Famciclovir Sales Market Share by Company (2020-2025)
Table 18. Global Famciclovir Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Famciclovir Revenue Market Share by Company (2020-2025)
Table 20. Global Famciclovir Sale Price by Company (2020-2025) & (USD/Unit)
Table 21. Key Manufacturers Famciclovir Producing Area Distribution and Sales Area
Table 22. Players Famciclovir Products Offered
Table 23. Famciclovir Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Famciclovir Sales by Geographic Region (2020-2025) & (K Units)
Table 27. Global Famciclovir Sales Market Share Geographic Region (2020-2025)
Table 28. Global Famciclovir Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Famciclovir Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Famciclovir Sales by Country/Region (2020-2025) & (K Units)
Table 31. Global Famciclovir Sales Market Share by Country/Region (2020-2025)
Table 32. Global Famciclovir Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Famciclovir Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Famciclovir Sales by Country (2020-2025) & (K Units)
Table 35. Americas Famciclovir Sales Market Share by Country (2020-2025)
Table 36. Americas Famciclovir Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Famciclovir Sales by Type (2020-2025) & (K Units)
Table 38. Americas Famciclovir Sales by Application (2020-2025) & (K Units)
Table 39. APAC Famciclovir Sales by Region (2020-2025) & (K Units)
Table 40. APAC Famciclovir Sales Market Share by Region (2020-2025)
Table 41. APAC Famciclovir Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Famciclovir Sales by Type (2020-2025) & (K Units)
Table 43. APAC Famciclovir Sales by Application (2020-2025) & (K Units)
Table 44. Europe Famciclovir Sales by Country (2020-2025) & (K Units)
Table 45. Europe Famciclovir Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Famciclovir Sales by Type (2020-2025) & (K Units)
Table 47. Europe Famciclovir Sales by Application (2020-2025) & (K Units)
Table 48. Middle East & Africa Famciclovir Sales by Country (2020-2025) & (K Units)
Table 49. Middle East & Africa Famciclovir Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Famciclovir Sales by Type (2020-2025) & (K Units)
Table 51. Middle East & Africa Famciclovir Sales by Application (2020-2025) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Famciclovir
Table 53. Key Market Challenges & Risks of Famciclovir
Table 54. Key Industry Trends of Famciclovir
Table 55. Famciclovir Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Famciclovir Distributors List
Table 58. Famciclovir Customer List
Table 59. Global Famciclovir Sales Forecast by Region (2026-2031) & (K Units)
Table 60. Global Famciclovir Revenue Forecast by Region (2026-2031) & ($ millions)
Table 61. Americas Famciclovir Sales Forecast by Country (2026-2031) & (K Units)
Table 62. Americas Famciclovir Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 63. APAC Famciclovir Sales Forecast by Region (2026-2031) & (K Units)
Table 64. APAC Famciclovir Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Europe Famciclovir Sales Forecast by Country (2026-2031) & (K Units)
Table 66. Europe Famciclovir Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Famciclovir Sales Forecast by Country (2026-2031) & (K Units)
Table 68. Middle East & Africa Famciclovir Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Global Famciclovir Sales Forecast by Type (2026-2031) & (K Units)
Table 70. Global Famciclovir Revenue Forecast by Type (2026-2031) & ($ millions)
Table 71. Global Famciclovir Sales Forecast by Application (2026-2031) & (K Units)
Table 72. Global Famciclovir Revenue Forecast by Application (2026-2031) & ($ millions)
Table 73. Novartis Basic Information, Famciclovir Manufacturing Base, Sales Area and Its Competitors
Table 74. Novartis Famciclovir Product Portfolios and Specifications
Table 75. Novartis Famciclovir Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Novartis Main Business
Table 77. Novartis Latest Developments
Table 78. Mylan Basic Information, Famciclovir Manufacturing Base, Sales Area and Its Competitors
Table 79. Mylan Famciclovir Product Portfolios and Specifications
Table 80. Mylan Famciclovir Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 81. Mylan Main Business
Table 82. Mylan Latest Developments
Table 83. Teva Basic Information, Famciclovir Manufacturing Base, Sales Area and Its Competitors
Table 84. Teva Famciclovir Product Portfolios and Specifications
Table 85. Teva Famciclovir Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. Teva Main Business
Table 87. Teva Latest Developments
Table 88. Cipla Basic Information, Famciclovir Manufacturing Base, Sales Area and Its Competitors
Table 89. Cipla Famciclovir Product Portfolios and Specifications
Table 90. Cipla Famciclovir Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 91. Cipla Main Business
Table 92. Cipla Latest Developments
Table 93. Hikma Basic Information, Famciclovir Manufacturing Base, Sales Area and Its Competitors
Table 94. Hikma Famciclovir Product Portfolios and Specifications
Table 95. Hikma Famciclovir Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 96. Hikma Main Business
Table 97. Hikma Latest Developments
Table 98. Apotex Basic Information, Famciclovir Manufacturing Base, Sales Area and Its Competitors
Table 99. Apotex Famciclovir Product Portfolios and Specifications
Table 100. Apotex Famciclovir Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 101. Apotex Main Business
Table 102. Apotex Latest Developments
Table 103. Aurobindo Pharma Basic Information, Famciclovir Manufacturing Base, Sales Area and Its Competitors
Table 104. Aurobindo Pharma Famciclovir Product Portfolios and Specifications
Table 105. Aurobindo Pharma Famciclovir Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 106. Aurobindo Pharma Main Business
Table 107. Aurobindo Pharma Latest Developments
Table 108. Macleods Pharmaceuticals Basic Information, Famciclovir Manufacturing Base, Sales Area and Its Competitors
Table 109. Macleods Pharmaceuticals Famciclovir Product Portfolios and Specifications
Table 110. Macleods Pharmaceuticals Famciclovir Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 111. Macleods Pharmaceuticals Main Business
Table 112. Macleods Pharmaceuticals Latest Developments
Table 113. Beijing Jialin Pharmaceutical Basic Information, Famciclovir Manufacturing Base, Sales Area and Its Competitors
Table 114. Beijing Jialin Pharmaceutical Famciclovir Product Portfolios and Specifications
Table 115. Beijing Jialin Pharmaceutical Famciclovir Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 116. Beijing Jialin Pharmaceutical Main Business
Table 117. Beijing Jialin Pharmaceutical Latest Developments
Table 118. HETERO Basic Information, Famciclovir Manufacturing Base, Sales Area and Its Competitors
Table 119. HETERO Famciclovir Product Portfolios and Specifications
Table 120. HETERO Famciclovir Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 121. HETERO Main Business
Table 122. HETERO Latest Developments
Table 123. Hainan choitec Pharmaceuticals Basic Information, Famciclovir Manufacturing Base, Sales Area and Its Competitors
Table 124. Hainan choitec Pharmaceuticals Famciclovir Product Portfolios and Specifications
Table 125. Hainan choitec Pharmaceuticals Famciclovir Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 126. Hainan choitec Pharmaceuticals Main Business
Table 127. Hainan choitec Pharmaceuticals Latest Developments
Table 128. Shandong Luoxin Pharmaceutical Group Basic Information, Famciclovir Manufacturing Base, Sales Area and Its Competitors
Table 129. Shandong Luoxin Pharmaceutical Group Famciclovir Product Portfolios and Specifications
Table 130. Shandong Luoxin Pharmaceutical Group Famciclovir Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 131. Shandong Luoxin Pharmaceutical Group Main Business
Table 132. Shandong Luoxin Pharmaceutical Group Latest Developments
Table 133. Chengdu Diao Pharmaceutical Group Basic Information, Famciclovir Manufacturing Base, Sales Area and Its Competitors
Table 134. Chengdu Diao Pharmaceutical Group Famciclovir Product Portfolios and Specifications
Table 135. Chengdu Diao Pharmaceutical Group Famciclovir Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 136. Chengdu Diao Pharmaceutical Group Main Business
Table 137. Chengdu Diao Pharmaceutical Group Latest Developments
Table 138. HISUN Basic Information, Famciclovir Manufacturing Base, Sales Area and Its Competitors
Table 139. HISUN Famciclovir Product Portfolios and Specifications
Table 140. HISUN Famciclovir Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 141. HISUN Main Business
Table 142. HISUN Latest Developments
LIST OF FIGURES
Figure 1. Picture of Famciclovir
Figure 2. Famciclovir Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Famciclovir Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Famciclovir Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Famciclovir Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Famciclovir Sales Market Share by Country/Region (2024)
Figure 10. Famciclovir Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of 125 mgTablets
Figure 12. Product Picture of 250 mgTablets
Figure 13. Product Picture of 500 mgTablets
Figure 14. Global Famciclovir Sales Market Share by Type in 2025
Figure 15. Global Famciclovir Revenue Market Share by Type (2020-2025)
Figure 16. Famciclovir Consumed in Cold Sores
Figure 17. Global Famciclovir Market: Cold Sores (2020-2025) & (K Units)
Figure 18. Famciclovir Consumed in Genital Herpes
Figure 19. Global Famciclovir Market: Genital Herpes (2020-2025) & (K Units)
Figure 20. Famciclovir Consumed in Shingles
Figure 21. Global Famciclovir Market: Shingles (2020-2025) & (K Units)
Figure 22. Global Famciclovir Sale Market Share by Application (2024)
Figure 23. Global Famciclovir Revenue Market Share by Application in 2025
Figure 24. Famciclovir Sales by Company in 2025 (K Units)
Figure 25. Global Famciclovir Sales Market Share by Company in 2025
Figure 26. Famciclovir Revenue by Company in 2025 ($ millions)
Figure 27. Global Famciclovir Revenue Market Share by Company in 2025
Figure 28. Global Famciclovir Sales Market Share by Geographic Region (2020-2025)
Figure 29. Global Famciclovir Revenue Market Share by Geographic Region in 2025
Figure 30. Americas Famciclovir Sales 2020-2025 (K Units)
Figure 31. Americas Famciclovir Revenue 2020-2025 ($ millions)
Figure 32. APAC Famciclovir Sales 2020-2025 (K Units)
Figure 33. APAC Famciclovir Revenue 2020-2025 ($ millions)
Figure 34. Europe Famciclovir Sales 2020-2025 (K Units)
Figure 35. Europe Famciclovir Revenue 2020-2025 ($ millions)
Figure 36. Middle East & Africa Famciclovir Sales 2020-2025 (K Units)
Figure 37. Middle East & Africa Famciclovir Revenue 2020-2025 ($ millions)
Figure 38. Americas Famciclovir Sales Market Share by Country in 2025
Figure 39. Americas Famciclovir Revenue Market Share by Country (2020-2025)
Figure 40. Americas Famciclovir Sales Market Share by Type (2020-2025)
Figure 41. Americas Famciclovir Sales Market Share by Application (2020-2025)
Figure 42. United States Famciclovir Revenue Growth 2020-2025 ($ millions)
Figure 43. Canada Famciclovir Revenue Growth 2020-2025 ($ millions)
Figure 44. Mexico Famciclovir Revenue Growth 2020-2025 ($ millions)
Figure 45. Brazil Famciclovir Revenue Growth 2020-2025 ($ millions)
Figure 46. APAC Famciclovir Sales Market Share by Region in 2025
Figure 47. APAC Famciclovir Revenue Market Share by Region (2020-2025)
Figure 48. APAC Famciclovir Sales Market Share by Type (2020-2025)
Figure 49. APAC Famciclovir Sales Market Share by Application (2020-2025)
Figure 50. China Famciclovir Revenue Growth 2020-2025 ($ millions)
Figure 51. Japan Famciclovir Revenue Growth 2020-2025 ($ millions)
Figure 52. South Korea Famciclovir Revenue Growth 2020-2025 ($ millions)
Figure 53. Southeast Asia Famciclovir Revenue Growth 2020-2025 ($ millions)
Figure 54. India Famciclovir Revenue Growth 2020-2025 ($ millions)
Figure 55. Australia Famciclovir Revenue Growth 2020-2025 ($ millions)
Figure 56. China Taiwan Famciclovir Revenue Growth 2020-2025 ($ millions)
Figure 57. Europe Famciclovir Sales Market Share by Country in 2025
Figure 58. Europe Famciclovir Revenue Market Share by Country (2020-2025)
Figure 59. Europe Famciclovir Sales Market Share by Type (2020-2025)
Figure 60. Europe Famciclovir Sales Market Share by Application (2020-2025)
Figure 61. Germany Famciclovir Revenue Growth 2020-2025 ($ millions)
Figure 62. France Famciclovir Revenue Growth 2020-2025 ($ millions)
Figure 63. UK Famciclovir Revenue Growth 2020-2025 ($ millions)
Figure 64. Italy Famciclovir Revenue Growth 2020-2025 ($ millions)
Figure 65. Russia Famciclovir Revenue Growth 2020-2025 ($ millions)
Figure 66. Middle East & Africa Famciclovir Sales Market Share by Country (2020-2025)
Figure 67. Middle East & Africa Famciclovir Sales Market Share by Type (2020-2025)
Figure 68. Middle East & Africa Famciclovir Sales Market Share by Application (2020-2025)
Figure 69. Egypt Famciclovir Revenue Growth 2020-2025 ($ millions)
Figure 70. South Africa Famciclovir Revenue Growth 2020-2025 ($ millions)
Figure 71. Israel Famciclovir Revenue Growth 2020-2025 ($ millions)
Figure 72. Turkey Famciclovir Revenue Growth 2020-2025 ($ millions)
Figure 73. GCC Countries Famciclovir Revenue Growth 2020-2025 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Famciclovir in 2025
Figure 75. Manufacturing Process Analysis of Famciclovir
Figure 76. Industry Chain Structure of Famciclovir
Figure 77. Channels of Distribution
Figure 78. Global Famciclovir Sales Market Forecast by Region (2026-2031)
Figure 79. Global Famciclovir Revenue Market Share Forecast by Region (2026-2031)
Figure 80. Global Famciclovir Sales Market Share Forecast by Type (2026-2031)
Figure 81. Global Famciclovir Revenue Market Share Forecast by Type (2026-2031)
Figure 82. Global Famciclovir Sales Market Share Forecast by Application (2026-2031)
Figure 83. Global Famciclovir Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Famciclovir
Figure 2. Famciclovir Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Famciclovir Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Famciclovir Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Famciclovir Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Famciclovir Sales Market Share by Country/Region (2024)
Figure 10. Famciclovir Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of 125 mgTablets
Figure 12. Product Picture of 250 mgTablets
Figure 13. Product Picture of 500 mgTablets
Figure 14. Global Famciclovir Sales Market Share by Type in 2025
Figure 15. Global Famciclovir Revenue Market Share by Type (2020-2025)
Figure 16. Famciclovir Consumed in Cold Sores
Figure 17. Global Famciclovir Market: Cold Sores (2020-2025) & (K Units)
Figure 18. Famciclovir Consumed in Genital Herpes
Figure 19. Global Famciclovir Market: Genital Herpes (2020-2025) & (K Units)
Figure 20. Famciclovir Consumed in Shingles
Figure 21. Global Famciclovir Market: Shingles (2020-2025) & (K Units)
Figure 22. Global Famciclovir Sale Market Share by Application (2024)
Figure 23. Global Famciclovir Revenue Market Share by Application in 2025
Figure 24. Famciclovir Sales by Company in 2025 (K Units)
Figure 25. Global Famciclovir Sales Market Share by Company in 2025
Figure 26. Famciclovir Revenue by Company in 2025 ($ millions)
Figure 27. Global Famciclovir Revenue Market Share by Company in 2025
Figure 28. Global Famciclovir Sales Market Share by Geographic Region (2020-2025)
Figure 29. Global Famciclovir Revenue Market Share by Geographic Region in 2025
Figure 30. Americas Famciclovir Sales 2020-2025 (K Units)
Figure 31. Americas Famciclovir Revenue 2020-2025 ($ millions)
Figure 32. APAC Famciclovir Sales 2020-2025 (K Units)
Figure 33. APAC Famciclovir Revenue 2020-2025 ($ millions)
Figure 34. Europe Famciclovir Sales 2020-2025 (K Units)
Figure 35. Europe Famciclovir Revenue 2020-2025 ($ millions)
Figure 36. Middle East & Africa Famciclovir Sales 2020-2025 (K Units)
Figure 37. Middle East & Africa Famciclovir Revenue 2020-2025 ($ millions)
Figure 38. Americas Famciclovir Sales Market Share by Country in 2025
Figure 39. Americas Famciclovir Revenue Market Share by Country (2020-2025)
Figure 40. Americas Famciclovir Sales Market Share by Type (2020-2025)
Figure 41. Americas Famciclovir Sales Market Share by Application (2020-2025)
Figure 42. United States Famciclovir Revenue Growth 2020-2025 ($ millions)
Figure 43. Canada Famciclovir Revenue Growth 2020-2025 ($ millions)
Figure 44. Mexico Famciclovir Revenue Growth 2020-2025 ($ millions)
Figure 45. Brazil Famciclovir Revenue Growth 2020-2025 ($ millions)
Figure 46. APAC Famciclovir Sales Market Share by Region in 2025
Figure 47. APAC Famciclovir Revenue Market Share by Region (2020-2025)
Figure 48. APAC Famciclovir Sales Market Share by Type (2020-2025)
Figure 49. APAC Famciclovir Sales Market Share by Application (2020-2025)
Figure 50. China Famciclovir Revenue Growth 2020-2025 ($ millions)
Figure 51. Japan Famciclovir Revenue Growth 2020-2025 ($ millions)
Figure 52. South Korea Famciclovir Revenue Growth 2020-2025 ($ millions)
Figure 53. Southeast Asia Famciclovir Revenue Growth 2020-2025 ($ millions)
Figure 54. India Famciclovir Revenue Growth 2020-2025 ($ millions)
Figure 55. Australia Famciclovir Revenue Growth 2020-2025 ($ millions)
Figure 56. China Taiwan Famciclovir Revenue Growth 2020-2025 ($ millions)
Figure 57. Europe Famciclovir Sales Market Share by Country in 2025
Figure 58. Europe Famciclovir Revenue Market Share by Country (2020-2025)
Figure 59. Europe Famciclovir Sales Market Share by Type (2020-2025)
Figure 60. Europe Famciclovir Sales Market Share by Application (2020-2025)
Figure 61. Germany Famciclovir Revenue Growth 2020-2025 ($ millions)
Figure 62. France Famciclovir Revenue Growth 2020-2025 ($ millions)
Figure 63. UK Famciclovir Revenue Growth 2020-2025 ($ millions)
Figure 64. Italy Famciclovir Revenue Growth 2020-2025 ($ millions)
Figure 65. Russia Famciclovir Revenue Growth 2020-2025 ($ millions)
Figure 66. Middle East & Africa Famciclovir Sales Market Share by Country (2020-2025)
Figure 67. Middle East & Africa Famciclovir Sales Market Share by Type (2020-2025)
Figure 68. Middle East & Africa Famciclovir Sales Market Share by Application (2020-2025)
Figure 69. Egypt Famciclovir Revenue Growth 2020-2025 ($ millions)
Figure 70. South Africa Famciclovir Revenue Growth 2020-2025 ($ millions)
Figure 71. Israel Famciclovir Revenue Growth 2020-2025 ($ millions)
Figure 72. Turkey Famciclovir Revenue Growth 2020-2025 ($ millions)
Figure 73. GCC Countries Famciclovir Revenue Growth 2020-2025 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Famciclovir in 2025
Figure 75. Manufacturing Process Analysis of Famciclovir
Figure 76. Industry Chain Structure of Famciclovir
Figure 77. Channels of Distribution
Figure 78. Global Famciclovir Sales Market Forecast by Region (2026-2031)
Figure 79. Global Famciclovir Revenue Market Share Forecast by Region (2026-2031)
Figure 80. Global Famciclovir Sales Market Share Forecast by Type (2026-2031)
Figure 81. Global Famciclovir Revenue Market Share Forecast by Type (2026-2031)
Figure 82. Global Famciclovir Sales Market Share Forecast by Application (2026-2031)
Figure 83. Global Famciclovir Revenue Market Share Forecast by Application (2026-2031)
